Sign in Create account

Samrat Pharmachem Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 530125
₹241.70
▲ 5.75 (2.44%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
42/100
Moderate
Valuation
98/100
Undervalued
Momentum
51/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹75 Cr
PE (TTM)
Data unavailable.
Price to Book
1.1
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-38.0
Free Cash Flow
₹6 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
483.78%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-80.83%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
4.68%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
482.53%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
5.43%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.86
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.16
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
-1.54
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
1.10%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
2.13%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
-0.33%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
2.56%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
-2.95%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
4.67%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.16)
  • No Return on equity is 15% or more (4.7%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 5 met
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
2.4%
Low 231.9500 · High 246.5000
1W return
7.5%
Low 220.4500 · High 246.5000
1M return
0.4%
Low 211.8500 · High 246.5000
52W return
-38.0%
Low 211.8500 · High 258.0000
Lifetime High ₹1202.1500 (Sept. 19, 2022)
Lifetime Low ₹6.4200 (May 14, 2009)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish3
Bearish3
5D
234.8
10D
232.0
20D
233.8
50D
258.1
100D
291.4
200D
339.7

Delivery and volume

Day avg. delivery
90.2%
Week avg. delivery
89.2%
Month avg. delivery
85.4%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

240.05
Pivot
First resistance248.15
Second resistance254.60
Third resistance262.70
First support233.60
Second support225.50
Third support219.05
Day RSI52.8
Day MFI52.4
Day MACD-5.84
Day MACD signal-9.80

Beta

1M0.33
3M-0.22
1Y-0.22
3Y0.47

Price change analysis

↑ 0.4%
Over 1 Month
LowHigh
211.85246.50
↓ -38.0%
Over 3 Months
LowHigh
211.85258.00
↓ -38.0%
Over 6 Months
LowHigh
211.85258.00
↓ -38.0%
Over 1 Year
LowHigh
211.85258.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹80 Cr
Net profit (June 30, 2026)
₹1 Cr
Basic EPS (June 30, 2026)
₹2.8400

Ranks #144 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter49.09%
  • FII/FPI3.24%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 49.09% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings were unchanged at 3.24% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 46 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
9 Sep 2024 GOLECHHA GLOBAL FINANCE LIMITED Bulk Sell 16,000 426.1600 BSE
7 Aug 2023 SETU SECURITIES PVT. LTD. Bulk Buy 15,602 344.4300 BSE
7 Aug 2023 SETU SECURITIES PVT. LTD. Bulk Sell 15,602 341.6500 BSE
7 Aug 2023 ALERT CONSULTANTS & CREDIT PRIVATE LIMITED Bulk Sell 21,769 345.7400 BSE
27 Jul 2023 GOLECHHA GLOBAL FINANCE LIMITED Bulk Sell 23,630 405.8200 BSE
18 Aug 2022 HARISHKUMARGUPTA Bulk Buy 22,000 629.2000 BSE
10 Jan 2022 MALA R BHAVNANI Bulk Sell 28,294 454.5300 BSE
7 Jan 2022 ADVANI PRIVATE LIMITED Bulk Buy 68,000 404.2200 BSE
7 Jan 2022 MALA R BHAVNANI Bulk Sell 78,000 404.4500 BSE
23 Dec 2021 TINA GOYAL Bulk Buy 18,800 322.5200 BSE

All bulk and block deals →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.16)
  • Healthy liquidity (Current Ratio 1.86)

Weaknesses

  • Low Return on Equity (4.7%)
  • Thin net profit margin (1.1%)

Opportunities

Data unavailable.

Threats

  • Down 38.0% over the past year
  • Weak interest coverage (-1.5x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Samrat Pharmachem Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.